© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 17, 1445-1447,
September 1, 1999
© 1999 Oxford University Press
NEWS |
New Estrogen Receptor Adds Complexity, Recasts Drug Strategies
Researchers studying estrogen signaling were thrown a curve ball in 1993 when mice with knocked-out estrogen receptor genes failed to display the severe deficits expected in estrogen-dependent cardiovascular and bone functions.
Subsequent studies have cleared up some of the resulting questions, while raising other questions and new therapeutic possibilities as well.
The knockout mice were sterile, with abnormal reproductive organs and bone growth. But even their survival was something of a surprise, suggesting the existence of another estrogen receptor. A report on a human knockout a man with a mutated ER gene described similar findings. The patient was normal in most respects but had incomplete closure of bone ends, which contributed to his 6-foot-8-inch height.
In
Daring Hypothesis
Superior SERMS
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K.-M. Lau, M. LaSpina, J. Long, and S.-M. Ho Expression of Estrogen Receptor (ER)-{{alpha}} and ER-{beta} in Normal and Malignant Prostatic Epithelial Cells: Regulation by Methylation and Involvement in Growth Regulation Cancer Res., June 1, 2000; 60(12): 3175 - 3182. [Abstract] [Full Text] |
||||
